Towards the Rational Design of Monovalent Degraders: Lessons Learnt from Cyclin K Degraders

Authors

  • Katie L. Thomas Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K. https://orcid.org/0000-0002-0569-190X
  • Benjamin R. Bellenie Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K. https://orcid.org/0000-0001-9987-3079
  • Olivia W. Rossanese Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K.

DOI:

https://doi.org/10.2533/chimia.2025.162

PMID:

40156561

Keywords:

Cyclin K, Monovalent degraders, Targeted protein degradation

Abstract

Monovalent degraders can enhance pre-existing surface complementarity between a target protein and a ligase to induce target degradation via the proteasome. For the most part, degraders have been discovered serendipitously and structure-activity relationship (SAR) studies have been limited, making it difficult to rationally design new compounds. Here we discuss how work on the SAR of cyclin K degraders demonstrates that a broad range of compounds can stabilise protein-protein interactions to induce degradation and how it lays the foundation for further monovalent degrader discovery.

Downloads

Published

2025-03-26

How to Cite

[1]
K. L. Thomas, B. R. Bellenie, O. W. Rossanese, Chimia 2025, 79, 162, DOI: 10.2533/chimia.2025.162.